Your browser doesn't support javascript.
loading
Health economic modeling for Alzheimer's disease: Expert perspectives.
Landeiro, Filipa; Morton, Jasmine; Gustavsson, Anders; Potashman, Michele; Lecomte, Pascal; Belger, Mark; Thompson, Robin; Roncancio-Diaz, Emilse; Jhuti, Gurleen; Butler, Christopher; Jönsson, Linus; Handels, Ron; Gray, Alastair M.
Afiliación
  • Landeiro F; Health Economics Research Centre Nuffield Department of Population Health University of Oxford Oxford UK.
  • Morton J; Health Economics Research Centre Nuffield Department of Population Health University of Oxford Oxford UK.
  • Gustavsson A; Division of Neurogeriatrics Department for Neurobiology Care Sciences and Society Karolinska Institutet Solna Sweden.
  • Potashman M; Quantify Research Stockholm Sweden.
  • Lecomte P; Value and Access, Biogen Cambridge Massachusetts USA.
  • Belger M; Global Head Health Economic Modelling and Methodology Novartis Pharma AG Basel Switzerland.
  • Thompson R; Global Statistical Sciences Eli Lilly and Company Windlesham UK.
  • Roncancio-Diaz E; Biogen International GmbH Baar Switzerland.
  • Jhuti G; GE Healthcare Life Sciences Amersham UK.
  • Butler C; Global Access Centre of Excellence F. Hoffmannn-La Roche Ltd. Basel Switzerland.
  • Jönsson L; Department of Brain Sciences Imperial College London London UK.
  • Handels R; Division of Neurogeriatrics Department for Neurobiology Care Sciences and Society Karolinska Institutet Solna Sweden.
  • Gray AM; H. Lundbeck A/S Valby Denmark.
Alzheimers Dement (N Y) ; 8(1): e12360, 2022.
Article en En | MEDLINE | ID: mdl-36313968
ABSTRACT
The successful development of an economic model for the evaluation of future Alzheimer's disease (AD) interventions is critical to accurately inform policy makers and payers. As our understanding of AD expands, this becomes an increasingly complex and challenging goal. Advances in diagnostic techniques for AD and the prospect of disease-modifying treatments raise an urgent need to define specifications for future economic models and to ensure that the necessary data to populate them are available. This Perspective article provides expert opinions from health economists and governmental agency representatives on how future economic models for AD might be structured, validated, and reported. We aim to stimulate much-needed discussion about the detailed specification of future health economic models for AD.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: Alzheimers Dement (N Y) Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: Alzheimers Dement (N Y) Año: 2022 Tipo del documento: Article